Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2019 Apr;22(4):e25279.
doi: 10.1002/jia2.25279.

Early outcomes after implementation of treat all in Rwanda: an interrupted time series study

Jonathan Ross  1 , Jean d'Amour Sinayobye  2 , Marcel Yotebieng  3 , Donald R Hoover  4 , Qiuhu Shi  5 , Muhayimpundu Ribakare  6 , Eric Remera  6 , Marcus A Bachhuber  1 , Gad Murenzi  2 , Vincent Sugira  2 , Denis Nash  7 , Kathryn Anastos  1 ; for Central Africa IeDEA
Affiliations
Observational Study

Early outcomes after implementation of treat all in Rwanda: an interrupted time series study

Jonathan Ross et al. J Int AIDS Soc. 2019 Apr.

Abstract

Introduction: Nearly all countries in sub-Saharan Africa have adopted policies to provide antiretroviral therapy (ART) to all persons living with HIV (Treat All), though HIV care outcomes of these programmes are not well-described. We estimated changes in ART initiation and retention in care following Treat All implementation in Rwanda in July 2016.

Methods: We conducted an interrupted time series analysis of adults enrolling in HIV care at ten Rwandan health centres from July 2014 to September 2017. Using segmented linear regression, we assessed changes in levels and trends of 30-day ART initiation and six-month retention in care before and after Treat All implementation. We compared modelled outcomes with counterfactual estimates calculated by extrapolating baseline trends. Modified Poisson regression models identified predictors of outcomes among patients enrolling after Treat All implementation.

Results: Among 2885 patients, 1803 (62.5%) enrolled in care before and 1082 (37.5%) after Treat All implementation. Immediately after Treat All implementation, there was a 31.3 percentage point increase in the predicted probability of 30-day ART initiation (95% CI 15.5, 47.2), with a subsequent increase of 1.1 percentage points per month (95% CI 0.1, 2.1). At the end of the study period, 30-day ART initiation was 47.8 percentage points (95% CI 8.1, 87.8) above what would have been expected under the pre-Treat All trend. For six-month retention, neither the immediate change nor monthly trend after Treat All were statistically significant. While 30-day ART initiation and six-month retention were less likely among patients 15 to 24 versus >24 years, the predicted probability of both outcomes increased significantly for younger patients in each month after Treat All implementation.

Conclusions: Implementation of Treat All in Rwanda was associated with a substantial increase in timely ART initiation without negatively impacting care retention. These early findings support Treat All as a strategy to help achieve global HIV targets.

Keywords: HIV; Africa; Treat All; antiretroviral therapy; retention in care; universal test and treat.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Proportion of patients (a) initiating antiretroviral therapy within 30 days of enrolment and (b) retained in care 6 months after enrolment in 10 health centres in Rwanda, 2014 to 2017.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. INSIGHT START Study Group , Lundgren JD, Babiker AG, Gordin F, Emery S, Grund B, Sharma S, et al. Initiation of antiretroviral therapy in early asymptomatic HIV infection. N Engl J Med. 2015;373(9):795–807. - PMC - PubMed
    1. TEMPRANO ANRS 12136 Study Group , Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, et al. A trial of early antiretrovirals and isoniazid preventive therapy in Africa. N Engl J Med. 2015;373(9):808–22. - PubMed
    1. Cohen MS, Chen YQ, McCauley M, Hosseinipour MC, Kumarasamy N, Hakim JG, et al. Prevention of HIV‐1 infection with early antiretroviral therapy. N Engl J Med. 2011;365(6):493–505. - PMC - PubMed
    1. World Health Organization . Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection 2016: recommendations for a public health approach. 2nd edition. Geneva, Switzerland: World Health Organization; 2016.
    1. Ford N, Vitoria M, Doherty M. Providing antiretroviral therapy to all who are HIV positive: the clinical, public health and programmatic benefits of Treat All. J Int AIDS Soc. 2018;21(2):e25078 - PMC - PubMed

Publication types

Substances